NCT00626015 2016-01-21
ZAP IT
Duke University
Phase 1 Completed
Clinical Trials
4 trialsNCT00019227 2013-06-20
Monoclonal Antibody Therapy in Treating Patients With Leukemia
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00002681 2011-06-10
Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma
Roger Williams Medical Center
Phase 1/2 Completed
NCT00847106 2009-02-19
Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients
Radboud University Medical Center
Phase 1/2 Completed